Yan Ding
Impact in
-
- Renal cell carcinoma treatment
- Molecular Biology top 10%
- Angiogenesis and VEGF in Cancer
- Ubiquitin and proteasome pathways
Papers in
-
- Neuroscience of respiration and sleep 4
-
- Renal cell carcinoma treatment 6
- Ferroptosis and cancer prognosis 2
- Co-authors
- Dan Huang (6 shared papers)Bin Tean Teh (5 shared papers)Chao‐Nan Qian (3 shared papers)David Petillo (2 shared papers)Kyle A. Furge (2 shared papers)Wang-Mei Luo (2 shared papers)Kristin J. VandenBeldt (2 shared papers)Richard J. Kahnoski (1 shared paper)
- Journals
- Cancer Research (4 papers)Cell Death and Disease (2 papers)Acta Biochimica et Biophysica Sinica (2 papers)Cell Death and Differentiation (2 papers)Acta Neurologica Scandinavica (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Yan Ding
48 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 87
- Pulmonary and Respiratory Medicine 402
- Molecular Biology 603
- Cancer Research 110
- Cell Biology 104
- Oncology 155
Countries citing papers authored by Yan Ding
This map shows the geographic impact of Yan Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Ding more than expected).
Fields of papers citing papers by Yan Ding
This network shows the impact of papers produced by Yan Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Ding. The network helps show where Yan Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Yan Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 357 | |
| 2 | 2010 | 197 | |
| 3 | 2008 | 183 | |
| 4 | 2008 | 107 | |
| 5 | 2012 | 84 | |
| 6 | 2019 | 79 | |
| 7 | VX680/MK-0457, a potent and selective Aurora kinase inhibitor, targets both tumor and endothelial cells in clear cell renal cell carcinoma. | 2010 | 48 |
| 8 | 2022 | 38 | |
| 9 | 2017 | 37 | |
| 10 | 2006 | 36 | |
| 11 | 2008 | 36 | |
| 12 | 2020 | 34 | |
| 13 | 2008 | 32 | |
| 14 | 2016 | 32 | |
| 15 | 2011 | 31 | |
| 16 | 2019 | 31 | |
| 17 | 2014 | 24 | |
| 18 | 2018 | 24 | |
| 19 | 2023 | 24 | |
| 20 | 2021 | 22 |
About Yan Ding
Yan Ding is a scholar working on Endocrine and Autonomic Systems, Pulmonary and Respiratory Medicine, Molecular Biology, Cell Biology and Immunology, having authored 51 papers that have together received 1.8k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (6 papers), Neuroscience of respiration and sleep (4 papers), Angiogenesis and VEGF in Cancer (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Melanoma and MAPK Pathways (3 papers), Hippo pathway signaling and YAP/TAZ (2 papers), Heme Oxygenase-1 and Carbon Monoxide (2 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (402 citations), Molecular Biology (603 citations), Cancer Research (110 citations), Cell Biology (104 citations) and Oncology (155 citations). Yan Ding has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Dan Huang, Bin Tean Teh, Chao‐Nan Qian, David Petillo, Kyle A. Furge, Wang-Mei Luo, Kristin J. VandenBeldt, Richard J. Kahnoski, Brian I. Rini and P. Andrew Futreal. Their work appears in journals such as Cancer Research, Cell Death and Disease, Acta Biochimica et Biophysica Sinica, Cell Death and Differentiation and Acta Neurologica Scandinavica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.